Blog Post

2022 Impact Report

2022 Impact Report

2022 Research Highlights (see details below)

  • Breakthrough gene therapy results showing rescue of FOXG1 brain structure, behavior, memory and cognition symptoms in animal models

  • Positive results on initial compound drug screens to identify molecules to increase FOXG1 levels; now moving forward to larger screens

  • Never-before understanding of FOXG1 biology uncovered from six FOXG1 patient human cell lines and mouse models 

  • Successful testing of guide RNAs to increase FOXG1 expression with a CRISPRa Cas-9 system

  • Discovered ASO sequences (antisense gene therapy) to modulate FOXG1 expression; testing initiated with Creyon Bio  

  • FOXG1 data package presented to several biotech companies with high interest


Help FOXG1 Ukrainian Family Rebuild!

Help FOXG1 Ukrainian Family Rebuild!

The FOXG1 Research Community has helped get a FOXG1 family safely out of the warn-torn Ukraine! Now, they have to rebuild thier lives. Eva is a 3-ear-old child with the severe rare disease called FOXG1 syndrome. She suffers from seizures and is disabled. They are on thier way to safely, but they lost everything. This is how you can help. Thank you!

Rare Disease Day 2021 : FOXG1 Syndrome

IMG_5862.jpeg

Rare Disease Day is a day to raise awareness about rare diseases like FOXG1 syndrome and their impact on patients' lives.

The research we fund at FRF not only has the potential to treat and cure FOXG1 syndrome, but provides pathways to cures for the 6,000+ other rare diseases that affect over 300 million people worldwide.

Please help us reach our goal to further cutting-edge research to find therapies for every child in the world with FOXG1 syndrome and to help pave the way for rare diseases at large.

Enjoy some Rare Disease Day 2021 FOXG1 Features




Please feel free to join us on this incredible mission! [email protected]

Thank you for your support!

"Inside Research with Nasha" - Repurposed Drug Screening for FOXG1

We’re kicking off a new series called “Inside Research with Nasha.

Our FOXG1 Research strategy is to leave no stone unturned. We’re looking at every possible angle in science to find disease-modifying therapies and ultimately a cure for FOXG1 syndrome and we want to keep everyone informed along the way. We’re also taking this opportunity to really explain what so many buzz words in science mean and how they fit into the research projects we are funding.

Today, we’re very excited to talk about our small molecule drug screening projects. Nasha explains some of those buzz words that covid made mainstream, like high-throughput screening, repurposing, small molecules, and more.

You can find more information about our Research Projects, our Path to a Cure and our FOXG1 Science Team on our website.

Please follow us on social @FOXG1Research so you don’t miss any of our Inside Research updates!

November 2020 Research Update : Creyon Bio Takes on FOXG1 for ASOs!

November 2020 FOXG1 Research Foundation Research Update: Two Biotech companies are investing in FOXG1 syndrome for gene therapy and ASO therapy. FOXG1 Research is moving into screening drugs and testing potential therapies with a newly assembled consortium of esteemed scientists.